Illumigene CMV Clinical Trial Protocol
Illumigene CMV Clinical Trial Protocol
To evaluate the illumigene CMV assay, using the illumipro-10 with neonates (up to 21 days of age) saliva swabs
Inclusion Criteria:
Exclusion Criteria:
Vancouver, British Coloumbia V6H 3N1, Canada
Via Massarenti 19, Province Of Bologna 40138, Italy